Human TNF-α monoclonal antibody( Simcere Pharmaceutical)
人鼠嵌合抗TNFα单克隆抗体（先声药业）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman TNF-α monoclonal antibody( Simcere Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesJiangsu Simcere Pharmaceutical Co LtdNanjing Simcere Dongyuan Pharmaceutical Co LtdShandong Xiansheng Zaiming Biopharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesShandong Xiansheng Zaiming Biopharmaceutical Co LtdJiangsu Simcere Pharmaceutical Co LtdNanjing Simcere Dongyuan Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A